SCM
Sandler Capital Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-57,718
| Closed | -$10.7M | – | 118 |
|
2024
Q4 | $10.7M | Buy |
57,718
+52,928
| +1,105% | +$9.77M | 1.11% | 5 |
|
2024
Q3 | $943K | Sell |
4,790
-18,131
| -79% | -$3.57M | 0.12% | 95 |
|
2024
Q2 | $4.74M | Sell |
22,921
-35,410
| -61% | -$7.31M | 0.51% | 47 |
|
2024
Q1 | $15.8M | Buy |
58,331
+26,831
| +85% | +$7.27M | 1.15% | 9 |
|
2023
Q4 | $7.45M | Buy |
31,500
+12,894
| +69% | +$3.05M | 0.62% | 43 |
|
2023
Q3 | $3.65M | Sell |
18,606
-52,051
| -74% | -$10.2M | 0.38% | 56 |
|
2023
Q2 | $14.9M | Buy |
70,657
+43,420
| +159% | +$9.13M | 1.22% | 21 |
|
2023
Q1 | $5.5M | Sell |
27,237
-94,163
| -78% | -$19M | 0.5% | 44 |
|
2022
Q4 | $26.5M | Buy |
+121,400
| New | +$26.5M | 2.71% | 4 |
|
2022
Q3 | – | Sell |
-23,575
| Closed | -$5.04M | – | 74 |
|
2022
Q2 | $5.04M | Sell |
23,575
-58,835
| -71% | -$12.6M | 0.54% | 44 |
|
2022
Q1 | $23.4M | Buy |
82,410
+58,227
| +241% | +$16.5M | 2.06% | 5 |
|
2021
Q4 | $9.11M | Sell |
24,183
-95,504
| -80% | -$36M | 0.79% | 33 |
|
2021
Q3 | $49.4M | Sell |
119,687
-57,680
| -33% | -$23.8M | 4.38% | 1 |
|
2021
Q2 | $65.6M | Sell |
177,367
-20,954
| -11% | -$7.75M | 5.12% | 1 |
|
2021
Q1 | $57.5M | Buy |
198,321
+10,280
| +5% | +$2.98M | 4.9% | 1 |
|
2020
Q4 | $47M | Buy |
188,041
+13,700
| +8% | +$3.42M | 5.49% | 1 |
|
2020
Q3 | $39.5M | Sell |
174,341
-49,941
| -22% | -$11.3M | 3.97% | 2 |
|
2020
Q2 | $39.1M | Buy |
224,282
+42,982
| +24% | +$7.49M | 3.72% | 1 |
|
2020
Q1 | $22.9M | Buy |
+181,300
| New | +$22.9M | 3.16% | 7 |
|
2015
Q4 | – | Sell |
-17,200
| Closed | -$1.09M | – | 113 |
|
2015
Q3 | $1.09M | Buy |
+17,200
| New | +$1.09M | 0.13% | 75 |
|
2015
Q2 | – | Sell |
-50,000
| Closed | -$3.97M | – | 155 |
|
2015
Q1 | $3.97M | Buy |
+50,000
| New | +$3.97M | 0.24% | 121 |
|